Leadership

David Gobel, Founder and Chief Executive Officer

Voraciously curious, a serial entrepreneur, an unrepentant do-gooder and a technology visionary, Dave has conceived many breakthrough technologies and then gone on to found or co-found private and venture capital backed companies and non-profits built to deliver those technologies.

Dave was the brains behind Knowledge Adventure, one of the earliest and most successful educational multimedia software developers to date; Worlds Inc., the inventor of shared virtual worlds over the internet and Starbright World, for Starbright Foundation, which was designed to allow hospital bound children to "go out and play" in a rich virtual world where they can communicate with friends and family.

Dave's father had died when he was only 55; as Dave approached that age he became curious and concerned about aging. Methuselah Foundation was formed to encourage and reward research that would shed light on the process of aging and find ways to extend healthy human life.

Executive Advisory Board

Roger Holzberg, Chief Executive Officer and Founder, My Bridge 4 Life / Creative Advisor, MFoundation

Roger is currently the (consulting) Creative Director for the Teams leading the “evolution” of the National Cancer Institute’s Cancer.Gov, and New Media (which recently launched NCI’s Facebook, Twitter and YouTube channels). As an award winning Vice President–Creative Director at Disney Imagineering he led the creative development for a broad portfolio ranging from playstation games to theme park icons; from mass audience interactive experiences and rides to the MMOG Virtual Magic Kingdom. In “classic media” he has written and directed feature films but is truly proud of writing “The Living Sea”, academy award nomination for documentary/IMAX.

Roger is a competitive triathlete and 6–year cancer survivor, both of these experiences led to his interest and commitment to advancing health and longevity.

Keith Murphy, Chief Executive Officer and President, Organovo, is a veteran of biotechnology startup Alkermes, Inc, where he played a central role on the development team for their first approved product, Nutropin (hGH) Depot.

He moved to Amgen in 1997 and developed several other novel formulation and device products. He has 16 years of experience in biotechnology, including serving in Product Strategy and Director of Process Development roles at Amgen.

His 10 years at Amgen included four years as Global Operations Leader for the largest development program in Amgen's history, Phase 3 osteoporosis/bone cancer drug denosumab.

He holds a BS in Chemical Engineering from MIT, and is an alumnus of the UCLA Anderson School of Management.

David Jacobs, Silverstone Solutions Founder & CEO.

David S. Jacobs started Silverstone Solutions, Inc. in 2006 as a result of his extensive experience in the software industry and his more recent experience as a medical patient.

Mr. Jacobs is a seasoned technology veteran with an exemplary track record of building fledging start-ups into successful global corporations. As a sales, marketing and business development executive, his ability to identify and capitalize on emerging markets is clearly established by a 25-year career building sales organizations for start-up companies that evolved into publicly traded corporations such as Microsoft, Marimba (now acquired by BMC Software) and Macromedia (now acquired by Adobe).

Mr. Jacobs' career was cut short by a genetic kidney disease, forcing him to resign as Vice President of Business Development for Macromedia, Inc., in the spring of 2001. He subsequently spent 3.5 years on the deceased donor organ waiting list and 1.5 year on dialysis while his health continued to decline. During this time, Mr. Jacobs identified a number of areas in the medical field that could be improved by technology solutions.

Having received a successful kidney transplant in December of 2004, Mr. Jacobs immediately began developing a paired-kidney exchange software application to make better use of available living donor organs for kidney transplantation.

Robert Cohen, Miromatrix CEO. He was vice president of business and technology development at St. Jude Medical, and a former CEO of Travanti Pharma Inc. and Advanced Circulatory Systems, Inc., after holding top positions with the Pfizer Hospital Products Group and Sulzer Medica.

Meet our Scientific Advisory Boards.